Azellon is a spin-out from The University of Bristol focused on the R&D and commercialisation of an adult autologous (patient's own) stem cell technology for the repair of avascular meniscal tears.
Posted on Tuesday, 21 June 2011 @ 17:37
Outstanding contributions to the commercialisation of university research were recognised at the PraxisUnico Conference 2011 in Glasgow on 10 June.
Posted on Tuesday, 21 June 2011 @ 17:36
Cambridge-based Lab21, which specialises in personalised medicine and clinical diagnostics, announced in May that it had acquired Myconostica, a molecular diagnostic company focusing on the diagnosis of fungal infections of clinical importance.
Posted on Tuesday, 21 June 2011 @ 17:35
IP Group plc (LSE: IPO) has issued a Prospectus for a proposed placing and open offer of 110 million new ordinary shares at the issue price of 50 pence each.
Posted on Tuesday, 21 June 2011 @ 17:34
The University of Strathclyde took the strategic decision to invest in EnviroCentre as a spin-out company in 1995, and the company has gone on to become one of Scotland’s leading environmental consultancies.
Posted on Tuesday, 21 June 2011 @ 17:32
In May the company completed a seed funding round of equity investment led by Mercia Fund Management, and announced its participation in a £2.1 million project funded by the TSB, EPSRC, and industrial partners.
Posted on Tuesday, 21 June 2011 @ 17:31
The Intellectual Property Office (IPO) launched in May a new strategy guide to help universities to develop and manage their intellectual assets.
Posted on Tuesday, 21 June 2011 @ 17:29
Lumora, a molecular diagnostics company which is developing next generation tests through its proprietary BART Technology platform, completed in May a £1.5 million funding round, led by Catapult Venture Managers.
Posted on Tuesday, 21 June 2011 @ 17:28
The SETsquared partnership has announced that one of the companies it has supported, Fitronics, has completed a successful sale of the business.
Posted on Tuesday, 21 June 2011 @ 17:25